Vanessa Broadhurst

EVP Vanessa Broadhurst sold 23,054 JNJ shares at $251.27 on 2026-07-20; reduced holdings by 50.1%

Vanessa Broadhurst, EVP of Global Corp Affairs, sold 23,054 shares of Johnson & Johnson at $251.27, reducing her non-derivative holdings from 46,057 shares to 23,003 shares—a 50.1% reduction. Her prior two sales at JNJ both demonstrated negative 90-day returns (-6.0% on 2026-02-17 and -9.5% on 2024-03-13), establishing a pattern of well-timed exits at this ticker. The current stock price of $250.61 is 7.0% below the 52-week high of $269.43, though trading 9.7% above its 30-day average. This sale represents a material reduction in her non-derivative stake concurrent with zero derivative holdings remaining, marking a significant portfolio adjustment by a senior executive.

EVP Vanessa Broadhurst sold 6,197 JNJ shares at $243.39 on 2026-02-17; holds 23,003 post-transaction. Prior JNJ sell was well-timed (-9.0% to -9.5% return).

Broadhurst's sale of 6,197 shares represents a 21.2% reduction in her JNJ position, executed at $243.39 while the stock currently trades at $244.99, near its 52-week high. Her single prior transaction in JNJ (a sale in March 2024) generated negative 90-day returns of -9.5%, ranking as well-timed per her cross-ticker track record of 100.0% well-timed sells. However, the cross-ticker track record is limited to 1 prior sell with an average 90-day return of -9.5%, making it a thin basis for pattern inference. The company's fundamentals remain solid: $24.0B in quarterly revenue, $5.2B net income, 6.0% annual growth, and a P/E of 15.59 at a $590.4B market cap. This transaction signals a material reduction in holdings rather than a minor rebalancing, yet without disclosed rationale or FLAGS indicating a 10b5-1 plan, the timing cannot be characterized strategically.